The board will support the CGT Catapult in identifying and removing barriers to the widespread adoption of advanced therapies ...

Rare diseases are defined as conditions affecting fewer than 200,000 people in the US or fewer than five in 10,000 individuals in the European Union ...

“The UK Singapore Chamber Trade Accelerator is a great initiative to help fast-track world-class UK innovation into one of ...

COVID-19 showed how quickly a health emergency becomes a fiscal event: disrupting supply chains, reshaping capital allocation ...

For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and ...

Competitive advantage: In a crowded therapeutic landscape, the ability to adapt quickly based on payer feedback can be a key ...

The NIRSE-GAL study, conducted in Galicia, Spain, is the first prospective real-world population study to evaluate the impact ...

At a time when asset development faces increasingly intensified pipeline competition and mounting launch pressures, and with ...

RFID has emerged as a key technology for its rapid, accurate data capture, and track and trace capabilities for manufacturing ...

In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver ...

Human Continuum has announced the appointment of Dr Omar Khalid Sial as Chief Scientific Officer (CSO).

The campaign repositions what is perceived as ‘normal’ in women’s health to support WOMEN | Bayer’s core message: ‘If it’s ...